Cargando…
Serum Metabolomics Benefits Discrimination Kidney Disease Development in Type 2 Diabetes Patients
BACKGROUND: Diabetic kidney disease (DKD) is the primary cause of end-stage renal disease, raising a considerable burden worldwide. Recognizing novel biomarkers by metabolomics can shed light on new biochemical insight to benefit DKD diagnostics and therapeutics. We hypothesized that serum metabolit...
Autores principales: | Peng, Xiaofeng, Wang, Xiaoyi, Shao, Xue, Wang, Yucheng, Feng, Shi, Wang, Cuili, Ye, Cunqi, Chen, Jianghua, Jiang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126316/ https://www.ncbi.nlm.nih.gov/pubmed/35615098 http://dx.doi.org/10.3389/fmed.2022.819311 |
Ejemplares similares
-
Identification of VCAN as Hub Gene for Diabetic Kidney Disease Immune Injury Using Integrated Bioinformatics Analysis
por: Xu, Qiannan, et al.
Publicado: (2021) -
Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing
por: Han, Shuai, et al.
Publicado: (2022) -
Role of Age-Related Changes in DNA Methylation in the Disproportionate Susceptibility and Worse Outcomes of Sepsis in Older Adults
por: Lang, Xiabing, et al.
Publicado: (2022) -
Novel Plasma Biomarker-Based Model for Predicting Acute Kidney Injury After Cardiac Surgery: A Case Control Study
por: Zhang, Yichi, et al.
Publicado: (2022) -
Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus
por: Zhou, Chunyu, et al.
Publicado: (2021)